ESR2 and neoplasm: Significant heterogeneity existed in the meta-analysis of the association of ERβ expression with non-tumor/tumor (I2 = 95.2%; P < 0.001), but not with gender (P = 0.559) or tumor grade (P = 0.453) or stage (P = 0.389).